- About Us
- Participant Zone
- Learning Zone
The Quantitative Faecal Hb programme is available as part of a comprehensive suite of programmes to assess and monitor the performance of the Clinical Biochemistry laboratory’s repertoire of both core and esoteric tests used for the diagnosis and monitoring of disease.
In July 2017 NICE published a diagnostic guidance document (DG30) that recommended the use of Faecal Immunochemical tests (FIT) in patients presenting to primary care with low risk symptoms for colorectal cancer.
Material is dispensed aseptically into buffered vials specific to each instrument manufacturer. The base material is organic material which closely mirrors the basic constituents of human faeces. This material is spiked with human whole blood (Hb) to cover the pathological and analytical range for Faecal Immunochemical tests (FIT). Samples challenging clinically relevant cut-offs for both symptomatic testing pathways and screening programmes.
|Quantitative Faecal Hb Programme|
|Analyte||Approx. Range Covered|
|Quantitative FIT||0 - 400||µg Hb/ g matrix|